Abstract:Atherosclerosis (AS) leads to atherosclerotic cardiovascular disease (ASCVD), the predominant cause of death worldwide. As traditional lipid-lowering therapies have encountered a bottleneck in dealing with diverse types of atherosclerotic plaques and ASCVD, alternative therapies that can target other mechanisms are urgently needed. Recent studies have revealed that AS is rooted in disrupted immune responses, such as chronic local inflammation and autoimmune responses, and immunotherapies have emerged as a nascent avenue to control plaque development owing to their satisfactory effects and high cost efficiency. The atherosclerotic immune microenvironment (AIME) is the microenvironment in which diverse immune responses occur dynamically. AIME is characterized by persistent inflammatory responses, shifted immunometabolism, and the formation of adventitial neuroimmune cardiovascular interfaces, all of which are regarded as prospective targets for AS immunotherapy. Recently, the advent of nanotechnology has advanced AS immunotherapy targeting the AIME. Manifold nanoplatforms have greatly enriched AS therapeutics owing to their multimodal imaging and multichannel intervention capabilities. Here, we offer an overview of AIME and discuss how nanomedicines can assist in AS diagnosis and intervention. We introduce nanoplatforms integrated with imaging techniques, such as magnetic resonance imaging, photoacoustic imaging, fluorescence imaging, positron emission tomography, and ultrasound imaging, which can target AIME to realize plaque diagnosis. Moreover, we elaborated on nanomaterials that regulate innate immune responses, adaptive immune responses, and aberrant immunometabolism to achieve AIME modulation. Furthermore, we highlight the possible future directions of AS therapeutics, with a focus on AIME-targeted nanomedicines.

New Progress of Image Technique in Atherosclerosis

New Progress in Early Diagnosis of Atherosclerosis

Progress and Perspective of Atherosclerosis-Targeted Molecular Probes: from Precise Imaging to Auxiliary Diagnosis and Treatment

Detection and Imaging of Active Substances in Early Atherosclerotic Lesions using Fluorescent Probes

Detection of arterial atherosderosis by molecular imaging

Advances of Optical Probes in Atherosclerosis Imaging

Targeted Imaging in Atherosclerosis.

Molecular and Nonmolecular Imaging of Macrophages in Atherosclerosis

Recent Progress in the Detection and Treatment of Atherosclerosis by Nanoparticles

Activatable fluorescent probes for atherosclerosis theranostics

Advances in nano-delivery systems based on diagnosis and theranostics strategy for atherosclerosis

Progress of CT aortic angiography combined with coronary artery in the evaluation of acute aortic syndrome

Design and Fabrication of Environmentally Responsive Nanoparticles for the Diagnosis and Treatment of Atherosclerosis

Omics research in atherosclerosis

Progress of Traditional Chinese Medicine in the prevention and treatment of arterial thrombosis

Shedding New Light on Atherosclerosis Therapeutics: Nanomedicines Targeting Atherosclerotic Immune Microenvironment

Recent Advances in Lipid-responsive Probes in the Imaging and Treatment of Atherosclerosis

A novel method for the diagnosis of atherosclerosis based on nanotechnology

Positron Emission Tomography Imaging of Athero

Emerging Nanoprobes for the Features Visualization of Vulnerable Atherosclerotic Plaques

Novel imaging modalities for the identification of vulnerable plaques